Eduardo Ramacciotti

Hospital E Maternidade Dr. Christóvão Da Gama
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Spot size variation and skin interaction of long-pulse 1064nm Nd: YAG laser used for varicose veins treatment: A prospective, randomized, assessor-blinded ex vivo study.

Spot size variation and skin interaction of long-pulse 1064nm Nd: YAG laser used for varicose veins treatment: A prospective, randomized, assessor-blinded ex vivo study.

Journal: Phlebology

Published: August 20, 2026

Q-switched and ultra-short-pulse Nd:YAG 1064 nm laser treatment for stasis dermatitis secondary to chronic venous hypertension: Rationale and design of the SUPERSTAR trial.

Q-switched and ultra-short-pulse Nd:YAG 1064 nm laser treatment for stasis dermatitis secondary to chronic venous hypertension: Rationale and design of the SUPERSTAR trial.

Journal: Phlebology

Published: June 23, 2026

Reply.

Reply.

Journal: Journal of vascular surgery. Venous and lymphatic disorders

Published: May 11, 2026

Transfixing Endovenous Thermal Ablation (TEThA) for varicose veins treatment - A prospective single-arm study.

Transfixing Endovenous Thermal Ablation (TEThA) for varicose veins treatment - A prospective single-arm study.

Journal: Phlebology

Published: February 14, 2026

Clinical profile, management and outcomes of patients taking dual pathway inhibition for cardiovascular protection in clinical practice in Latin America. Data from the XATOA registry.

Clinical profile, management and outcomes of patients taking dual pathway inhibition for cardiovascular protection in clinical practice in Latin America. Data from the XATOA registry.

Journal: Drugs in context

Published: January 19, 2026

Treatment of supratrochlear and supraorbital veins with long-pulsed 1064-nm Nd: YAG laser: A single-arm prospective pilot study.

Treatment of supratrochlear and supraorbital veins with long-pulsed 1064-nm Nd: YAG laser: A single-arm prospective pilot study.

Journal: Phlebology

Published: January 06, 2026

A randomized controlled trial of 3% polidocanol foam with saline prewashing compared with standard foam sclerotherapy for the treatment of varicose veins.

A randomized controlled trial of 3% polidocanol foam with saline prewashing compared with standard foam sclerotherapy for the treatment of varicose veins.

Journal: Journal of vascular surgery. Venous and lymphatic disorders

Published: December 31, 2025

A randomized controlled trial of 3% polidocanol foam with saline pre-washing compared to standard foam sclerotherapy for the treatment of varicose veins.

A randomized controlled trial of 3% polidocanol foam with saline pre-washing compared to standard foam sclerotherapy for the treatment of varicose veins.

Journal: Journal of vascular surgery. Venous and lymphatic disorders

Published: December 31, 2025

Pulsed Electromagnetic Field Therapy Compared to Conventional Mechanical Prophylaxis for Venous Thromboembolism Prophylaxis in The Intensive Care Unit - Rationale and Design for The SOPHIE Trial.

Pulsed Electromagnetic Field Therapy Compared to Conventional Mechanical Prophylaxis for Venous Thromboembolism Prophylaxis in The Intensive Care Unit - Rationale and Design for The SOPHIE Trial.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: November 18, 2025

Biomarker Analysis from the Compass Claudication Study - Rivaroxaban for Intermittent Claudication.

Biomarker Analysis from the Compass Claudication Study - Rivaroxaban for Intermittent Claudication.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: October 23, 2025

Transdermal radiofrequency (V ERASER®) plus polidocanol sclerotherapy versus polidocanol sclerotherapy alone for the treatment of reticular veins and telangiectasias. A randomized controlled trial (TYPER trial).

Transdermal radiofrequency (V ERASER®) plus polidocanol sclerotherapy versus polidocanol sclerotherapy alone for the treatment of reticular veins and telangiectasias. A randomized controlled trial (TYPER trial).

Journal: Phlebology

Published: September 04, 2025

Venous Thromboembolism in Patients Receiving Rivaroxaban Plus Aspirin or Standard Treatment after Lower Limb Revascularization-Rationale and Design of the RESOLUTION Trial.

Venous Thromboembolism in Patients Receiving Rivaroxaban Plus Aspirin or Standard Treatment after Lower Limb Revascularization-Rationale and Design of the RESOLUTION Trial.

Journal: Annals of vascular surgery

Published: July 27, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026